{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:59:50Z","timestamp":1754600390583,"version":"3.41.2"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>The expeditious and world pandemic viral disease of new coronavirus (SARS-CoV-2) has formed a prompt urgency to discover auspicious target-based ligand for the treatment of COVID-19. Symptoms of novel coronavirus disease (COVID-19) typically include dry cough, fever, and shortness of breath. Recent studies on many COVID-19 patients in Italy and the United Kingdom found increasing anosmia and ageusia among the COVID-19-infected patients. SARS-CoV-2 possibly infects neurons in the nasal passage and disrupts the senses of smell and taste, like other coronaviruses, such as SARS-CoV and MERS-CoV that could target the central nervous system. Developing a drug based on the T2Rs might be of better understanding and worth finding better molecules to act against COVID-19. In this research, we have taken a taste receptor agonist molecule to find a better core molecule that may act as the best resource to design a drug or corresponding derivatives. Based on the computational docking studies, the antibiotic tobramycin showed the best interaction against 6LU7 COVID-19 main protease. Aromatic carbonyl functional groups of the molecule established intermolecular hydrogen bonding interaction with GLN189 amino acid and it showed the two strongest carbonyl interactions with receptor protein resulting in a glide score of \u221211.159. To conclude, depending on the molecular recognition of the GPCR proteins, the agonist molecule can be recognized to represent the cell secondary mechanism; thus, it provides enough confidence to design a suitable molecule based on the tobramycin drug.<\/jats:p>","DOI":"10.3389\/fmolb.2021.637124","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T13:57:51Z","timestamp":1629208671000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Computational Studies on T2Rs Agonist-Based Anti\u2013COVID-19 Drug Design"],"prefix":"10.3389","volume":"8","author":[{"given":"Premnath","family":"Dhanaraj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indiraleka","family":"Muthiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahtabin Rodela","family":"Rozbu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samiha","family":"Nuzhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mosae Selvakumar","family":"Paulraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"099","DOI":"10.1385\/cbb:41:1:099","article-title":"Molecular Basis of Bitter Taste: The T2R Family of G Protein-Coupled Receptors","volume":"41","author":"Andres-Barquin","year":"2004","journal-title":"Cbb"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3389\/fphar.2020.01095","article-title":"Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy","volume":"11","author":"Aoe","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1002\/alr.22692","article-title":"November). Does Phenotypic Expression of Bitter Taste Receptor T2R38 Show Association with COVID\u201019 Severity?","author":"Barham","year":"2020","journal-title":"Int. Forum Allergy rhinology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"9646","DOI":"10.1128\/jvi.05327-11","article-title":"Inhibition of HIV-1 Integration in Ex Vivo-infected CD4 T Cells from Elite Controllers","volume":"85","author":"Buzon","year":"2011","journal-title":"J. Virol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/d41586-020-02544-6","article-title":"The Coronavirus Is Mutating - Does it Matter?","volume":"585","author":"Callaway","year":"2020","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-39939-z","article-title":"Merits and Pitfalls of Conventional and Covalent Docking in Identifying New Hydroxyl Aryl Aldehyde like Compounds as Human IRE1 Inhibitors","volume":"9","author":"Carlesso","year":"2019","journal-title":"Scientific Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/08820139309063393","article-title":"HLA Class I Antigen Serves as a Receptor for Human Coronavirus OC43","volume":"22","author":"Collins","year":"1993","journal-title":"Immunological Invest."},{"key":"B8","first-page":"100124","volume-title":"From SARS to COVID-19: A Previously Unknown SARS-CoV-2 Virus of Pandemic Potential Infecting Humans\u2013Call for a One Health ApproachOne Health","author":"El Zowalaty","year":"2020"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"ftw004","DOI":"10.1093\/femspd\/ftw004","article-title":"Sensing Developing Biofilms: the Bitter Receptor T2R38 on Myeloid Cells","volume":"74","author":"Gaida","year":"2016","journal-title":"Pathog. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1096\/fj.201800521rr","article-title":"Chemosensory Bitter Taste Receptors (T2Rs) Are Activated by Multiple Antibiotics","volume":"33","author":"Jaggupilli","year":"2019","journal-title":"FASEB j."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2020.201.1_meetingabstracts.a7478","article-title":"First Contact: The Role of Respiratory Cilia in Host-Pathogen Interactions in the Airways","author":"Kuek","year":"2020","journal-title":"Am. J. Physiology-Lung Cell Mol. Physiol."},{"key":"B13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbamem.2018.01.014","article-title":"Plasticity of the Ligand Binding Pocket in the Bitter Taste Receptor T2R7","volume":"5","author":"Liu","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembranes"},{"key":"B14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.wjorl.2018.07.003","article-title":"The Role of Bitter and Sweet Taste Receptors in Upper Airway Innate Immunity: Recent Advances and Future Directions","volume":"4","author":"Maina","year":"2018","journal-title":"World J. Otorhinolaryngol. - Head Neck Surg."},{"key":"B15","first-page":"568","article-title":"Intense Bitterness of Molecules: Machine Learning for Expediting Drug Discovery","volume-title":"Comput. Struc. Biotec. J.","author":"Margulis","year":"2020"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2000607","DOI":"10.1362\/147539220x16003502334181","article-title":"Pathogenesis of COVID-19 from a Cell Biology Perspective","volume":"55","author":"Mason","year":"2020","journal-title":"Eur. Respir. J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fimmu.2015.00369","article-title":"Tasting \u201cPseudomonas Aeruginosabiofilms: Human Neutrophils Express the Bitter Receptor T2R38 as Sensor for the Quorum Sensing Molecule N-(3- Oxododecanoyl)-L-Homoserine Lactone","volume":"6","author":"Maurer","year":"2015","journal-title":"Front. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1783365","article-title":"In Silico structure Prediction, Molecular Docking and Dynamic Simulation Studies on G Protein-Coupled Receptor 116: a Novel Insight into Breast Cancer Therapy","author":"Muthiah","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B19","first-page":"185","article-title":"The Molecular Docking Study of Potential Drug Candidates Showing Anti-COVID-19 Activity by Exploring of Therapeutic Targets of SARS-CoV-2","volume":"4","author":"Narkhede","year":"2020","journal-title":"J. Med. Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1128\/cmr.00045-07","article-title":"Respiratory Viruses Other Than Influenza Virus: Impact and Therapeutic Advances","volume":"21","author":"Nichols","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-25640-0","article-title":"Early Events during Human Coronavirus OC43 Entry to the Cell","volume":"8","author":"Owczarek","year":"2018","journal-title":"Scientific Rep."},{"key":"B22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.saa.2015.08.008","article-title":"Synthesis and Spectroscopic Characterization of Fluorescent 4-aminoantipyrine Analogues: Molecular Docking and Invitro Cytotoxicity Studies","volume":"153","author":"Premnath","year":"2015","journal-title":"Spectrochimica Acta A: Mol. Biomol. Spectrosc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"117652","DOI":"10.1016\/j.lfs.2020.117652","article-title":"In Silico studies on Therapeutic Agents for COVID-19: Drug Repurposing Approach","volume":"252","author":"Shah","year":"2020","journal-title":"Life Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"46166","DOI":"10.1038\/srep46166","article-title":"Bitter Taste Receptor Agonists Mitigate Features of Allergic Asthma in Mice","volume":"7","author":"Sharma","year":"2017","journal-title":"Sci. Rep."},{"key":"B25","first-page":"2170","article-title":"Challenges of Drug Development during the COVID-19 Pandemic: Key Considerations for Clinical Trial Designs","volume-title":"Brit. J. Clin. Pharmacol.","author":"Shi","year":"2020"},{"key":"B26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/v11010059","article-title":"From SARS to MERS, Thrusting Coronaviruses into the Spotlight","volume":"11","author":"Song","year":"2019","journal-title":"Viruses"},{"key":"B27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 Entry Factors Are Highly Expressed in Nasal Epithelial Cells Together with Innate Immune Genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural Basis of SARS-CoV-2 3CLpro and Anti-COVID-19 Drug Discovery from Medicinal Plants","volume":"10","author":"Ul Qamar","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"B30","unstructured":"Coronavirus Mutation May Have Made it More Contagious. ScienceDaily2020"},{"key":"B31","doi-asserted-by":"publisher","first-page":"9234","DOI":"10.1128\/jvi.74.19.9234-9239.2000","article-title":"Human Coronavirus 229E Infects Polarized Airway Epithelia from the Apical Surface","volume":"74","author":"Wang","year":"2000","journal-title":"J. Virol."},{"key":"B32","doi-asserted-by":"crossref","first-page":"106012","DOI":"10.1016\/j.ijantimicag.2020.106012","article-title":"Computational Screening of Antagonist against the SARS-CoV-2 (COVID-19) Coronavirus by Molecular Docking","volume":"56","author":"Yu","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B33","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.1148\/radiol.2020200490","article-title":"Coronavirus Disease 2019 (COVID-19): A Perspective from China","volume":"296","author":"Zu","year":"2020","journal-title":"Radiology"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2021.637124\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T13:57:59Z","timestamp":1629208679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2021.637124\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":33,"alternative-id":["10.3389\/fmolb.2021.637124"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2021.637124","relation":{},"ISSN":["2296-889X"],"issn-type":[{"type":"electronic","value":"2296-889X"}],"subject":[],"published":{"date-parts":[[2021,8,17]]},"article-number":"637124"}}